Comprehensive Pan-Cancer Analysis of the Prognostic Role of KLF Transcription Factor 2 (KLF2) in Human Tumors
Rong Xu,Yuhan Chen,Shicai Wei,Jun Chen
DOI: https://doi.org/10.2147/ott.s476179
IF: 4
2024-11-03
OncoTargets and Therapy
Abstract:Rong Xu, 1 Yuhan Chen, 2 Shicai Wei, 1 Jun Chen 1 1 Department of Dermatology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China; 2 Department of Pathology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, People's Republic of China Correspondence: Jun Chen; Shicai Wei, Department of Dermatology, The Fourth Affiliated Hospital of Nanjing Medical University, No. 298, Nanpu Road, Yanjiang Street, Pukou District, Nanjing, People's Republic of China, Email ; Background: KLF2 is a transcription factor expressed early in mammalian development that plays a role in many processes of development and disease. Recently, increasing studies revealed that KLF2 plays a key role in the occurrence and progression of cancer. Purpose: The aim of this study was to explore the role of KLF2 in various tumor types using the Cancer Genome Atlas dataset. Methods: Here, we set out to explore the role of KLF2 in 33 tumor types using TCGA (The Cancer Genome Atlas), GEO (Gene Expression Omnibus) dataset, Human Protein Atlas (HPA), UALCAN database, CancerSEA, GSCALite and several bioinformatic tools. Furthermore, we also performed immunohistochemistry and qPCR to further validate the role of KLF2 in multiple cancers and its correlation with prognosis. Results: We found that KLF2 was underexpressed in most tumors and generally predicted poor OS in tumor patients. We found that amplification of KLF2 may be a risk factor for patients with OV (Ovarian serous cystadenocarcinoma). We also analyzed the abundance of checkpoints and markers of specific immune subsets including CD8+ T lymphocytes (T cells), CD4+ T cells, macrophages, and endothelial cells that significantly correlated with the expression level of KLF2 in pan-carcinoma tissues. In some cancers, KLF2 expression levels are positively correlated with gene promoter DNA methylation and drug sensitivity. In addition, we found that KLF2 is involved in single-cell level cell invasion in some cancers. In addition, KLF2 is co-expressed with several intracellular signal transduction genes involved in immune system processes. Immunohistochemistry and qPCR confirmed the low expression of KLF2 in STAD (stomach adenocarcinoma) and renal cancer. Conclusion: Our pan-cancer analysis provides a comprehensive overview of the oncogenic roles of KLF2 in multiple human cancers and can be regarded as a potential prognostic marker and a novel target for cancer immunotherapy. Keywords: KLF2, cancer, bioinformatics, prognosis, immune infiltration The incidence and mortality of malignant tumors are on the rise, which has become the second leading cause of death in the world. 1 With the in-depth understanding of the underlying mechanisms of tumorigenesis, the treatment options for malignant tumors continue to expand. In recent years, more and more attention has been paid to tumor immunotherapy, including immune checkpoint blocking therapy and immune cell therapy. 2 The specificity of immunotherapy depends heavily on the specific tumor antigen. 3 However, immunotherapy-related biomarker matching tests are still limited in most cancers. 4 Therefore, there is an urgent need to further explore effective immunotherapy-related tumor prognostic biomarkers. KLF2 (Krüppel-like factor 2) is a member of the Kruppel-like transcription factor protein family and contains a highly conserved DNA-binding zinc finger domain. 5 The name of the family is based on the German words "cripple" and "Krüppel" describing the drosophila loss function of phenotypic variation with abnormal abdominal segmentation in the region of larvae. 6 KLF2 was named Lung KLF2 after Anderson et al (1995) found its high expression in lung. 7 Zinc finger proteins encoded by KLF2 are expressed early in mammalian development and are present in many different cell types. 8 This protein plays an important role in many processes of normal development and disease, including adipogenesis, embryonic erythropoiesis, intact epithelium formation, and activation of T lymphocytes (T cells), which the main mechanism is to activate the transcription process of target genes by binding to the CACCC box in the promoter of target genes. 9 There was a plethora of study data linking KLF2 to several forms of malignancies. klf2 was shown to be downregulated in gastric cancer, 10 clear cell renal cell carcinoma, 11 colorectal cancer 12 and breast cancer. 13 However, a comprehensive analysis of the function and clinical importance of KLF2 at the pan-cancer level has not been performed. DNA methylation is critical for -Abstract Truncated-
oncology,biotechnology & applied microbiology